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Abstract High-throughput molecular studies are
greatly advancing our knowledge of the human
microbiome and its specific role in governing health
and disease states. A myriad of ongoing studies aim at
identifying links between microbial community dise-
quilibria (dysbiosis) and human diseases. However,
due to the inherent complexity and heterogeneity of
the human microbiome we need robust experimental
models that allow the systematic manipulation of
variables to test the multitude of hypotheses arisen
from large-scale ‘meta-omic’ projects. The nematode
C. elegans combined with bacterial models offers an
avenue to dissect cause and effect in host-microbiome
interactions. This combined model allows the genetic
manipulation of both host and microbial genetics and
the use of a variety of tools, to identify pathways
affecting host health. A number of recent high impact
studies have used C. elegans to identify microbial
pathways affecting ageing and longevity, demonstrat-
ing the power of the combined C. elegans-bacterial
model. Here I will review the current state of the field,
what we have learned from using C. elegans to study
gut microbiome and host interactions, and the poten-
tial of using this model system in the future.
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Introduction
Humans coexist in a mutualistic relationship with a
diverse gut microbial ecosystem consisting of mainly
bacteria, but also viruses, fungi and protozoa. The gut
microbiome consists of more than 5 million genes, a
genome that is two orders of magnitude than the
human genome (Sommer and Ba¨ckhed 2013). The
interactions between the host and the microbiota is
highly interdependent and it has been suggested that
humans should be considered as superorganisms in
which the microbial symbionts play essential physi-
ological functions (Fritz et al. 2013). The microbiome
can directly affect host physiology by providing food
and essential metabolic compounds and inhibiting
pathogen colonization by limiting resources available
to the invading microbes or competing for attachment
sites on the surface of intestinal epithelial cells, or by
directly modulating immune system maturation. Con-
versely, the microbiome has been found to be asso-
ciated with chronic inflammation (Fritz et al. 2013)
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and dysbiosis, and imbalance in the microbiome has
been linked to diseases such as inflammatory bowel
disease, diabetes mellitus, obesity, cardiovascular
disease and cancer (Sommer and Ba¨ckhed 2013).
Our current understanding of the human gut
microbiota mainly relies on metagenomics profiling.
Over the last decade, large-scale metagenomics
sequencing studies of human faecal samples have
identified many hundreds of species, common sets of
microbial species, as well as inter-individual variation.
Combined data from the MetaHit and the Human
Microbiome Project have provided the most compre-
hensive view of the composition of the human gut
microbiota, identifying a total of 2172 species isolated
from human beings, classified into 12 different phyla,
of which the large majority belong to the phyla
Proteobacteria, Firmicutes, Actinobacteria and Bac-
teroidetes (Schloissnig et al. 2012; Arumugam et al.
2011; Gill et al. 2006; Methe´ et al. 2012). Further
studies have used functional omic approaches to
attempt to determine which microbial species that
are active by identifying microbial proteins and
metabolites in faecal samples (Verberkmoes et al.
2009; Gosalbes et al. 2011; Roume et al. 2013;
Maurice et al. 2014), and how microbial metabolites
are affected in disease states (Jansson et al. 2009).
Together these approaches are generating many
hypotheses regarding the association between the
composition of the gut microbiota and human health.
The gut microbiota is linked to the ageing process
Considering the many physiological effects of the gut
microbiota, it is not surprising that the gut microbiota
is also linked to the ageing process of the host. The
composition of the gut microbiota changes dramati-
cally during ageing (O’Toole and Jeffery 2015).
Healthy gut microbiota is characterised by bacterial
taxonomic diversity, while age and frailty is associated
with Bacteroidetes dominated populations, expansion
of more pathogenic bacterial species and amuch larger
variation between individuals (Claesson et al. 2011;
Claesson et al. 2016). Studies of centenarians have
shown that their microbiota differs from those of older
adults (Biagi et al. 2010; Jeffery et al. 2016),
consistent with general age-related microbiota trends.
The numerous metagenomic studies have enabled
the definition of a healthy baseline microbiota and
generated many hypotheses regarding the association
between the composition of the gut microbiota,
diseases and the ageing process. These hypotheses
include effects on frailty (Claesson et al. 2016), gut
health (Biagi et al. 2010), brain plasticity and cogni-
tive function (Leung and Thuret 2015), inflammation
(Biagi et al. 2010), metabolic syndrome (Sepp et al.
2014), immunity (Zwielehner et al. 2009) and long-
evity (Biagi et al. 2010). We now need robust
experimental models that allow the systematic manip-
ulation of variables to test the hypotheses arisen from
large-scale metagenomic projects and identify the
molecular mechanisms underlying the effects of
microbial genes on general health and ageing (Fritz
et al. 2013).
Available models to study the effect of the gut
microbiota on ageing
Germ-free (GF) mice are the most commonly used
animal models to study host-microbe interactions. GF
mice are raised in sterile conditions, have no microor-
ganisms living in them and can bemade gnotobiotic by
colonization with single microbial species, allowing
the impact of specific microorganisms to be studied.
These kind of studies have shown that the gut
microbiota is important for a number of physiological
processes in the host including homeostasis, immune
system function, development and metabolism (Som-
mer and Ba¨ckhed 2013). The main challenges with
using this model is that maintaining the mice sterile is
an expensive and labour intensive challenge, making it
a slow, tedious and low-throughput approach. Labo-
ratory mice have a lifespan of approximately 3 years,
making the use of gnotobiotic mice in ageing studies
even more cost some and challenging (Cho and Blaser
2012).
In addition to mice, zebra fish is being established
as a model organism to study ageing and the micro-
biota, but with a lifespan similar to the mouse lifespan,
and tank-based husbandry, it also offers a slow low-
throughput approach. Therefore, complementary
approaches allowing unbiased high-throughput meth-
ods are needed, which can elucidate the mechanisms
underlying host-microbiota interactions in vivo (Pham
et al. 2008).
The nematode C. elegans offers an avenue to
dissect the cause and effect by allowing the genetic
manipulation of both host and microbial genetics to
identify pathways affecting host health. A number of
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Table 1 Publications identifying worm-bug interactions resulting in longevity
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recent studies have identified microbial pathways
affecting ageing and longevity inC. elegans (Table 1),
opening for the possibility to further develop this
model to understand the role of the gut microbiota in
disease states and ageing. Here I will review the
current state of the field, what we have learned so far
from using the nematode to study gut microbiome and
host interactions, and how C. elegans can be further
exploited to dissect of complex interactions and
mechanisms between the host and its microbiota.
The worm-bug: a high throughput model of host-
microbiota interactions
The nematode C. elegans has many inherent advan-
tages as a model. It has a short life cycle of 3 days, a
large brood size and a lifespan of 3 weeks, and is
inexpensive and easy to cultivate in the laboratory. C.
elegans has two sexes: the hermaphrodite, which is
self-fertilizing and isogenic, and males, allowing
genetic exchange and genetic crosses. C. elegans is
transparent, allowing imaging of tissues and cells
in vivo, without the need of dissection. This model
organism also offers many useful tools to dissect
complex biological pathways. There are publicly
available genetic mutants from the Caenorhabditis
Genetics Center, and genome wide RNA interference
libraries (Fraser et al. 2000), allowing high-throughput
genetic screens. Many additional tools have been
developed allowing high-throughput approaches of
e.g. survival measurements (Stroustrup et al. 2016;
Churgin et al. 2017). The body of C. elegans is
transparent, allowing the use of fluorescent reporters
in vivo. Importantly, C. elegans is well-established as
an ageing research model and has enabled the identi-
fication of pathways influencing ageing, such as the
insulin/IGF-1 (IIS) and mTOR pathways, which are
evolutionary conserved in mammals (Kenyon 2010).
Approximately 50% of theC. elegans genes have clear
human orthologues, making C. elegans ideal to study
pathways highly relevant to human biology.
C. elegans is a bacterivore, and in the wild C.
elegans feeds on bacteria that proliferate in decaying
organic material, and harbour a diverse bacterial flora
in their guts (Schulenburg and Fe´lix 2017). In terms of
the viability and evolution of C. elegans and its
microbes, it is regarded as an indivisible entity, called
the ‘‘worm-bug’’ (Cabreiro and Gems 2013). In
addition to all the advantages C. elegans offers on its
own as a laboratory model system, it has been
combined with another very successful model,
E. coli. In the laboratory, C. elegans is maintained on
a monoxenic culture, typically of the Escherichia coli
B bacterial strain OP50, using standard microbiology
techniques. In addition, other strains such as Bacillus
subtilis and E. coli HT115 are also routinely used
(Cabreiro andGems 2013). The easily obtained control
of the gut microbiota in C. elegans allows the
dissection not only of host pathways, but also of
bacterial pathways, and complex interactions between
the host and the microbiota. E. coli is the most
thoroughly studied species on the planet, has well-
established genetics and offers many tools such as
genome editing, genetic engineering and online
databases for analysis of genetic and biochemical
functions. Combining the advantages of E. coli and C.
elegans into the worm-bug model system is proving to
yield a very powerful combined model system. For
example, the E. coli Keio deletion collection contain-
ing approximately 4000 mutants covering 93% of
E. coli genes can be used to screen for host phenotypes,
and this approach has successfully been used to
identify bacterial pathways affectingC. elegans ageing
(Virk et al. 2016; Han et al. 2017). This approach is not
limited to E. coli, as there are additional collections in
other species (Zhang et al. 2017).
The use of the worm-bug model consisting of a host
with a single microbial species as its microbiota offers
many advantages in terms of experimental tractability.
Furthermore, inexpensive and straight forward culti-
vation, combined with the short lifespan of C. elegans,
makes this model system an ideal addition to existing
mammalian models to dissect the role of the gut
microbiota in human health and ageing. Recent years
have seen several high-profile studies using the worm-
bug, identifying a number of bacterial and host
interactions promoting host longevity.
Bacterial folate metabolism promotes longevity
One of the most well studied microbial pathway to
affect C. elegans longevity is folate metabolism. The
folate cycle is a series of metabolic steps found in all
cells, including both bacteria and animals, required for
cell biosynthesis. The products include purines,
pyrimidines, glycine, andmethionine, and are required
570 Biogerontology (2018) 19:567–578
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to generate the methyl donor molecule S-adenosyl
methionine (SAM), which occupies a central role for
metabolism of all cells. Folates in their reduced
tetrahydrofolate form act as enzymatic cofactors in the
folate cycle, and since animals cannot synthesize
folates, folates are obtained from their diets and
microbiota (Virk et al. 2012).
Disruption of E. coli folate synthesis promotes
longevity in C. elegans. Para-aminobenzoic acid
(PABA) is a folate precursor. A partial screen of the
Keio E. coli mutant library identified several muta-
tions in enzymes involved in the synthesis of PABA,
aroD, pabaA and pabaB, which increase lifespan in C.
elegans. Sulfamethoxazole (SMX), a sulfonamide
drug that competes with PABA for the active site of
the enzyme dihydropteroate synthase, also increases
lifespan in C. elegans. Reducing folate uptake or
metabolism directly in the host does not affect
lifespan, showing that lifespan is extended as a result
of alterations in bacterial metabolism (Virk et al. 2016;
Virk et al. 2012).
Important clues regarding the mechanisms under-
lying bacterial folate metabolism and host ageing have
come from studies using the biguanide metformin, an
oral drug widely prescribed to treat type 2 diabetes.
The biological activity of metformin goes beyond its
antihyperglycemic effects, and has been shown to
reduce the risk of cancer (Dowling et al. 2011) and
delay ageing in rodents (Anisimov et al. 2011).
Metformin also extends lifespan in C. elegans (Onken
and Driscoll 2010), and this effect is dependent on
bacterial activity. In the absence of E. coli, or in the
presence of dead E. coli, metformin is toxic and
shortens lifespan. A key player in this bacterial effect
is folate metabolism; Metformin does not increase
lifespan when mutations in folate cycle enzymes are
introduced into E. coli and pharmacological inhibition
of folate synthesis in E. coli mimics metformin
treatment. Furthermore, metformin changes the folate
composition in E. coli, but not in C. elegans. Changes
in the folate cycle result in perturbations of bacterial
methionine metabolism, leading to methionine restric-
tion and activation of the metabolic sensor AMP-
activated protein kinase (AMPK) in the host, mim-
icking molecular features of dietary restriction (Cab-
reiro et al. 2013).
Collectively these studies show that microbial
metabolism can alter ageing in the host, and identify
the microbial and host pathways underlying these
effects, demonstrating that the worm-bug combined
model provides an excellent framework to explore the
effects of gut microbiota on ageing. They also raise the
question if alterations in the bacterial folate and
methionine can mimic dietary restriction and alter
ageing in humans as well, and if the gut microbiota can
be used for pharmacological interventions.
Bacterially derived NO enhances host lifespan
and stress tolerance
In addition to changes in bacterial metabolism,
secreted microbial compounds and signals, such as
nitric oxide (NO) have been found to promote
longevity in C. elegans. NO has many important
functions, including affecting neurotransmission,
immunity and cardiovascular function by affecting
protein function directly and indirectly via post-
translational modifications. Although most eukaryotes
have endogenous enzymes, NO synthases (NOS), that
generate NO, C. elegans is unusual in the sense that it
has no genes that encode NOS and does not produce
NO by NOS-dependent synthesis (Gusarov et al.
2013).
Since NO is a small molecule that diffuses freely
across cellular compartments and membranes, NO
produced by bacteria can diffuse into worm tissues and
affect worm physiology. Rather than using the stan-
dard laboratory E. coli strain OP50, Gusarov et al.
(Gusarov et al. 2013) used Bacillus subtilis, a soil
bacteria that naturally populates the C. elegans’ gut,
and produces NO (Gusarov et al. 2013). B. subtilis is
known to extend lifespan compared to E. coli (Garsin
2003), and Gusarov et al. showed that the mechanisms
of these longevity effects involve bacterial production
of NO in the worm gut, which diffuses to other tissues
and initiates a signalling cascade, resulting in a
transcriptional response. The transcriptional response
involves the longevity genes daf-16,C. elegans FOXO
which acts downstream of reduced IIS, and hsf-1, the
C. elegans heat shock factor 1. DAF-16 is a transcrip-
tion factor controlling many aspects of physiology and
has broad effects on ageing (Kenyon 2010), while
HSF-1 mainly acts by regulating the transcription of
small heat shock factor proteins. Thus, NO produced
by the gut microbiota acts to increase lifespan by
activating longevity pathways in the host, providing an
Biogerontology (2018) 19:567–578 571
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example of interspecies signalling by a small
molecule.
Bacterial biofilms promote host health
and longevity by reducing IIS
In most laboratory studies, bacteria are grown in
shaken-liquid medium, which favours bacteria that
grow well in suspension. However, in nature, most
bacteria grow in biofilms, that is aggregated to each
other and to solid surfaces, and embedded within a
slimy extracellular matrix composed of extracellular
polymers, including proteins and polysaccharides.
Bacteria in biofilms have an unexpectedly high degree
of coordinated multi-cellular behaviours that have led
to the perception of biofilms as ‘‘cities’’ of microor-
ganisms. In the biofilms bacteria regulate diverse
physiological processes and group activities through
quorum sensing, a mechanism in which bacterial cells
produce, detect and respond to small diffusible signal
molecule (Li and Tian 2016).
There is a growing appreciation that, although
clearly worthwhile, studies of standard planktonic
cultures (single cells floating in liquid) provide us with
a biased view of microbial life. The cells in a biofilm
are embedded within an extracellular polysaccharide
matrix that has been reported to provide the embedded
bacteria with protection against a variety of environ-
mental stresses, and interactions among microorgan-
isms in a biofilm enhance nutrient availability and
remove toxic metabolites. Thus, bacteria in a biofilm
have different characteristics than the same bacteria in
isolation (Verhagen et al. 2011).
Two recent studies using B. subtilis, a long-serving
model for biofilm formation, in combination with C.
elegans, show that biofilms have beneficial effects on
host health and longevity, and shines light on some of
the mechanisms involved (Donato et al. 2017; Smo-
lentseva et al. 2017). Donato et al. compared a wild
undomesticated strain of B. subtilis with the standard
domesticated strains of B. subtilis and E. coli. To
promote biofilm formation, they used sporulated
forms of B. subtilis, which survive the transit through
the pharynx and germinate in the worm intestine. The
domesticated B. subtilis strain increased lifespan and
tolerance to different stresses, but all these effects
were even more pronounced when fed the undomes-
ticated strain. Why does the undomesticated B. subtilis
strain extend lifespan compared to the domesticated
strain? The authors found that the undomesticated
strain colonised the C. elegans gut to a larger extent,
and that the effect on both gut colonisation and
lifespan depended on the ability to form biofilms.
Three different strains deficient in the ability to form
biofilms due to mutations in tasA and epsG, which are
key components of the extracellular matrix of the
biofilm, and in the bslA gene which encodes for an
essential hydrophobin responsible for the formation of
the hydrophobic surface layer that surrounds and
protects the biofilm, were tested. The mutations
suppressed the longevity effects of the undomesticated
strain and reduced gut colonisation compared with the
wildtype undomesticated strain, without having sporu-
lation or nutritional effects. Also, the decrease in
worm longevity produced by feeding worms each
biofilm-defective strain correlated with a decreased
bacterial proficiency in gut colonisation (Donato et al.
2017).
Smolentseva et al found similar effects in non-
sporulating B. subtilis. They first confirmed that non-
sporulating B. subtilis also form biofilms inside the C.
elegans gut, and then compared biofilm-producing B.
subtilis with biofilm-deficient B. subtilis mutants, and
showed that production of biofilm results in increased
lifespan and resistance to heat, oxidative stress and
pathogenic infection, and improved late-life motility.
These effects require mtl-1, a host gene encoding
metallothionein, a small cysteine-rich metal-binding
protein, which is regulated by DAF-16/FOXO. This
study argues that the longevity effects do not require
the extracellular matrix itself, but rather that it is the
metabolic status of the biofilm producing bacteria that
extends lifespan (Smolentseva et al. 2017). Further-
more, the effects of biofilm have been suggested to
involve secretion of NO and CSF, a quorum sensing
peptide (Donato et al. 2017), but these effects were
contradicted by Smolentseva et al (Smolentseva et al.
2017).
Together these studies show that microbial coloni-
sation and biofilms have beneficial effects on host
longevity and healthspan, and identify some of the
host pathways mediating the responses to the biofilms.
The implication of these studies is that bacterial
biofilms, and secreted compounds such as NO, act
through the classical longevity pathway DAF-16/
FOXO and promote longevity by reducing IIS. Further
studies will elucidate the details of these interactions
572 Biogerontology (2018) 19:567–578
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and the mechanisms underlying the effect of biofilms
on IIS.
High-throughput approaches uncover bacterial
effects on host mitochondria
An important advantage with C. elegans is the
possibility to use high-throughput approaches to
perform large unbiased screens over a range of
conditions. Such an approach was used to screen the
entire Keio E. coli mutant library, covering almost
4000 genes in an E. coli K-12 BW25113 background,
and resulting in the identification of 29 bacterial genes
that increase lifespan (Han et al. 2017). The large
majority of these bacterial genes act through well
characterised longevity pathways in the host, includ-
ing the IIS and mTOR signalling pathways, but two of
the mutants, Dhns and Dlon, increase lifespan inde-
pendently of known longevity pathways. hns encodes
a global DNA-binding transcriptional dual regulator,
and lon a DNA-binding ATP-dependent protease.
Both transcriptional regulators suppress production of
colonic acid (CA), a polysaccharide secreted by many
enterobacterial species, resulting in high levels of CA
secretion in the mutants and longevity in the host. By
knocking down a number of C. elegans genes and
performing imaging and functional analysis, the
authors showed that bacterial CA regulates host
mitochondrial dynamics. CA is taken up by the host
intestine through endocytosis, increases mitochondrial
fission in the intestine, acts through mitochondrial
respiration and induces transcription of mitochondrial
chaperones through mitochondrial UPR (Han et al.
2017).
Supplementation of CA to wildtype bacteria phe-
nocopies the mutant effect not only in E. coli, but also
in several other bacterial strains. However, CA
supplementation does not increase lifespan in the
standard laboratory OP50 strain, which is naturally lon
deficient and already has higher levels of CA,
highlighting the importance of the genetic background
of bacterial strains on longevity. In contrast to NO,
biofilms and folate, the longevity effect of CA does not
require live bacteria, meaning that CA alone is enough
to exert its beneficial effects and does not act through
changes bacterial metabolism (Han et al. 2017).
Why improving intestinal mitochondrial homeosta-
sis increases healthspan and lifespan remains to be
explored, but intestinal health has previously been
shown to be important for longevity (Ezcurra et al.
2017; Libina et al. 2003), and this study shows how the
gut bacteria can act directly to improve intestinal
health. The discovery of the influence of CA on host
physiology reveals an interesting crosstalk between
bacterial signalling and mitochondria in animal hosts.
Since CA is produced in response to stress on the part
of the bacteria, worms may have evolved response
pathways that read bacterial stress in the gut and
initiate response pathways as means to offset impend-
ing adverse conditions (Gruber and Kennedy 2017).
This study is an excellent example of how the
worm-bug offers the possibility of using high-through-
put approaches to perform unbiased screens to identify
bacterial determinants of late life health, and deter-
mine the physiological mechanisms in the host
underlying these effects. Importantly, this study goes
beyond studying host lifespan, and shows that CA not
only increases lifespan but also suppress age-related
disease models and delays the onset of muscular
mitochondrial fragmentation and locomotor decline.
The study also demonstrates how worm-bug can be
used as a platform to discover mechanisms conserved
in higher organisms, as CA increases lifespan in
Drosophila and promotes mitochondrial fragmenta-
tion in a murine cell line, opening for the possibility
that CA could promote healthy ageing in humans.
Detrimental effects of dysbiosis during ageing
During ageing, changes in the composition of the
human gut microbiota take place (Biagi et al. 2012).
Dysbiosis has been associated not only with ageing but
also with many diseases, including obesity, type 2
diabetes, and arthritis (Sommer and Ba¨ckhed 2013;
O’Toole and Jeffery 2015; Cho and Blaser 2012), but
the causality between microbial diversity and host
health remains unexplored. The mechanisms underly-
ing age-related dysbiosis are likely to be complex and
multi-factored, and studies using C. elegans offer
means to identify microbial and host processes
contributing to dysbiosis.
Like humans, C. elegans suffers from age-related
dysbiosis, and bacterial proliferation of E. coli OP50
in the C. elegans gut has been implicated as a major
contributor of mortality (Gems and Riddle 2000;
Garigan et al. 2002; Portal-celhay et al. 2012). During
Biogerontology (2018) 19:567–578 573
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its life course, the relationship between C. elegans and
E. coli changes. In early life, E. coli OP50 mainly acts
as a food source, and living, metabolically active
bacteria are required for normal development and
fertility. As the nematodes reach adulthood, E. coli
OP50 starts proliferating within the gut lumen, and as
the animals age, there is a large increase in bacterial
load in the gut lumen, accompanied by bacterial
packing and constipation (Cabreiro and Gems 2013;
Garigan et al. 2002; Portal-celhay et al. 2012; Gomez
et al. 2012).
A number of studies and approaches confirm that
E. coli is pathogenic in late life. Inhibiting bacterial
growth by antibiotic treatment increases lifespan
(Gems and Riddle 2000; Garigan et al. 2002; Portal-
celhay et al. 2012; Podshivalova et al. 2017), and
animals with colonised guts have shorter lifespan than
animals with non-colonised guts (Podshivalova et al.
2017) suggesting that E. coli proliferates and colonises
the gut of the host. Furthermore, inhibiting bacterial
respiration by introducing mutations in the electron
transport chain reduces age-related bacterial prolifer-
ation and extends lifespan. This effect is not due to
dietary restriction or to compounds released by the
bacteria, but rather by lack of bacterial respiration
itself, resulting in reduced bacterial growth and
suppressed bacterial colonisation of the gut (Saiki
et al. 2011; Gomez et al. 2012). Thus, with age, the
relationship to E. coli changes from being necessary
and beneficial to being detrimental and pathogenic,
resulting in dysbiosis, colonisation of the gut and
mortality. This is not true for all bacterial strains, e.g.
the longevity effect of biofilm formation by B. subtilis
requires bacterial growth, and in this context antibi-
otics shorten lifespan (Smolentseva et al. 2017). Thus,
the effect of bacterial proliferation and dysbiosis is
dependent on the bacterial species and its relationship
to the host.
Age-related processes in the host contribute to age-
related dysbiosis
The effect of dysbiosis during ageing is also dependent
on age-related processes in the host contributing to
vulnerability to bacterial proliferation in late life. One
such process is immunosenescence, the decline of the
immune system that occurs during ageing. C. elegans
has an innate immune system with evolutionarily
conserved signalling; anti-microbial innate immunity
is modulated by pathways involving the DAF-16/
FOXO transcriptional regulator, the PMK-1 p38 MAP
kinase, and DBL-1, homologous to human transform-
ing growth factor b (TGF-b). Knocking down genes in
these pathways results in increased bacterial prolifer-
ation and decreased host lifespan (Portal-celhay et al.
2012) and there is a strong correlation between
immunity decline, increased dysbiosis and mortality.
Thus, the ageing process results in decreased effi-
ciency of innate immunity to provide host defence and
a loss in the capacity to control bacteria within the gut,
and dysbiosis, at least partly regulated by immunose-
nescence, plays a role in the determination of host
lifespan (Portal-celhay et al. 2012).
Other host processes are also involved in determin-
ing the effect of bacterial proliferation during ageing.
These relate to the decline of tissues that are in direct
contract with the gut microbiota, the pharynx and the
intestine. The pharynx breaks down bacterial cells
during feeding, and age-related decline of the pharynx
results in increased bacterial load and bacterial
invasion (Garigan et al. 2002; Portal-celhay et al.
2012; Gomez et al. 2012; Zhao et al. 2017). The gut,
which digests food and provides a barrier to the
external world, also exhibits severe decline during
ageing (Herndon et al. 2002), a process that is likely to
contribute to increased vulnerability to bacterial
pathogens (Youngman et al. 2011). Death is accom-
panied by an increase of bacterial density in the
pharynx and the proximal intestine, but long-lived
animals with reduced IIS are protected, and die much
later without bacterial colonisation (Podshivalova
et al. 2017; Zhao et al. 2017). Collectively, these
studies show that ageing and death is accompanied by
bacterial proliferation and tissue invasion, showing
that dysbiosis plays an important role in C. elegans
ageing, and that longevity at least in is be due to
resistance to bacteria. An interesting twist to these
findings is that even though inhibiting bacterial
proliferation increases lifespan by 40%, it does not
increase healthspan in terms of late-life mobility, and
animals treated with antibiotics spend a large section
of their life living in decrepitude (Podshivalova et al.
2017). The relationship between between the gut
microbiota, host health and ageing is proving to be
complex, and there is a need to measure more
parameters than just survival when performing ageing
studies.
574 Biogerontology (2018) 19:567–578
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The different host processes contributing to dys-
biosis are not necessarily independent. Immunosenes-
cence has been suggested to cause pharyngeal and
intestinal decline (Zhao et al. 2017; Youngman et al.
2011), and reduced IIS signalling protects against
immunosenescence, pharyngeal and intestinal decline
(Garsin 2003; Garigan et al. 2002; Podshivalova et al.
2017; Herndon et al. 2002), supporting the idea that
the decline of tissues and immune system are linked.
Thus, dysbiosis is likely to be the result of a negative
cycle of tissue aging, immunosenescence, and pro-
gressive intestinal proliferation of E. coli towards the
end of life in the host (Youngman et al. 2011).
Discovering the C. elegans native microbiome
and its effect on life history
One important question is to what extent studies using
laboratory conditions and E. coli OP50 reflects the
relationship between C. elegans and its microbiota in
the wild. Decades of studyingC. elegans in the lab and
feeding it with domesticated E. coli OP50 has left us
with little understanding of how C. elegans interacts
with its natural microbiota. E. coliOP50 was chosen as
food source because OP50 forms thinner bacterial
lawns, easing visual inspection of C. elegans, and due
to the availability of OP50 in research laboratories, not
because of any resemblance to microbes in the C.
elegans natural habitats (Samuel et al. 2016). Thus C.
elegans has been studied in highly artificial laboratory
conditions.
Our understanding of C. elegans and the relation-
ship to its natural microbiome is now changing as the
result of three studies published in 2016. Using partly
overlapping and complementary approaches, these
studies used next generation sequencing to charac-
terise the native microbiome of C. elegans, either in
their natural habitats (Samuel et al. 2016; Dirksen
et al. 2016), or in microcosms emulating natural
habitats (Berg et al. 2016). The identified C. elegans
microbiome is a rich and diverse microbiome domi-
nated by Proteobacteria such as Enterobacteriaceae,
Pseudomonas, Stenotrophomans, Ochrobactrum and
Sphingomonas, and Bacteroidetes, Firmicutes, and
differ from the microbial communities in the soil
environment, suggesting that host factors influence the
microbial composition and that C. elegans has a
defined, non-randommicrobiome (Dirksen et al. 2016;
Berg et al. 2016). Several additional pieces of
evidence support this claim. For example, micro-
biomes of worms collected from different sampling
sites are more similar to each other than to the
environmental microbiome (Dirksen et al. 2016; Berg
et al. 2016), the C. elegans microbiome is distinct
compared to the microbiome of closely related
nematodes (Berg et al. 2016), and animals collected
from the wild maintain their microbiota when culti-
vated in the lab (Dirksen et al. 2016).
Identification and isolation of the natural micro-
biome has also allowed the testing of how different
species affect host fitness in a laboratory setting.
Samuel et al. established culture collections of over
500 wild bacterial strains isolated from the C. elegans
natural environment, and examined them by growing
animals on the individual strains and assaying growth
rate and responses to a range of stress and immune
reporter genes. 78% of the strains were found to be
beneficial, having a higher growth rate and no
induction of stress reporters, and 22% to be detrimen-
tal, having a slower growth rate and induction of
reporters, relative to animals grown on E. coli OP50.
The effects tended to be genera-specific; several
Proteobacteria, including Enterobacteriaceae, Glu-
conobacter, Enterobacter, Providencia and most
Lactococcus strains were beneficial to C. elegans.
Detrimental genera included Bacteroidetes, such as
Chryseobacterium and Sphingobacterium, and poten-
tially pathogenic Gammaproteobacteria (e.g., Xan-
thomonas and Stenotrophomonas) (Samuel et al.
2016).
Using a different approach, Dirksen et al. and
constructed an experimental microbiome by selecting
a subset of 14 isolates representing the most abundant
genera of the C. elegansmicrobiome isolated from the
wild. Growing animals on the experimental micro-
biome revealed that bacterial strain frequencies within
the gut are distinct from the strain frequencies of the
bacterial culture, e.g. Ochrobactrum and Stenootro-
phomans isolates was only found as small traces in
culture, but formed 20% of the bacterial communities
within C. elegans, and are likely to be part of the C.
elegans core microbiome. The experimental micro-
biome increases population size and enhances worm
fitness in comparison to E. coli OP50, not only in
standard laboratory conditions but also under different
stress conditions. Also in this study analysis of
individual bacterial isolates identified that the positive
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effects on population size are likely caused by
Proteobacteria (Dirksen et al. 2016). Future studies
will identify the positive interactions between Pro-
teobacteria and C. elegans.
The identification of the native gut microbiome
opens for many new possibilities using C. elegans to
understand interactions between the gut microbiome
and the host, including aspects shaped by evolution in
natural environments, and undetectable in artificial
environments using E. coli OP50 as the only food
source. Considering all the effects on fitness already
identified in these three initial studies, it would be
surprising if the native gut microbiota also doesn’t also
affect healthspan and longevity. Studies of the native
gut microbiota are only in its infancy, and coming
years will provide us with insight into the role the
native the gut microbiota plays in the biology of the
host, including ageing.
Future perspectives
Studies in humans and mice suggest that the gut
microbiome plays a role in ageing, but this complex
relationship is very difficult to disentangle in higher
animals. Recent studies using C. elegans combined
with bacterial models are starting to provide mecha-
nistic insight into the effects of the gut microbiome on
ageing (Table 1). Collectively, they provide with
examples of how bacterial metabolism promotes host
longevity, including bacterial pathways such as the
folate cycle, methionine metabolism, biofilm forma-
tion, suppression of CA production and reduction of
bacterial respiration. They also strongly suggest that
bacterial pathways offer a range of possible interven-
tions to improve late life health in the host.
In addition to microbial pathways, host responses
mediating the bacterial effects on longevity have been
identified and include conserved longevity pathways,
such as DAF-16/FOXO, mTOR and HSF-1 signalling.
The activation of longevity pathways by bacteria is not
exclusive to the laboratory strains E. coli OP50 and B.
subtilis. Bacterial strains isolated from the human gut,
including from human centenarians, have also been
shown to activate longevity pathways and promote
longevity and health in C. elegans (Grompone et al.
2012; Zhao et al. 2017; Nakagawa et al. 2016). The
mechanisms by which bacterial signals activate long-
evity pathways remain to be understood, and will be a
considerable challenge for future studies, but it is
likely that their activation by microbes could be
exploited to improve health and ageing in humans.
One remaining question is if the gut microbiota can
promote improved ageing through pathways other
than classical longevity pathways. The majority of the
recent studies reviewed here have used candidate gene
approaches to identify host pathways responding to the
microbiome, however C. elegans is very well suited
for unbiased approaches to identify novel pathways.
Replacing candidate gene approaches with screening
of mutant and RNAi libraries will allow identification
of novel ways by which the host responds to the
bacteria. This will be further helped by new automated
approaches to measure lifespan and healthspan.
Recently several automated systems have been devel-
oped, including the Lifespan Machine, where the
survival rates of large populations of animals are
monitored using flatbed scanners (Stroustrup et al.
2016), and the WormMotel, a microfabricated device
for long-term cultivation and automated longitudinal
imaging of large numbers of individual animals
(Churgin et al. 2017). These and other similar systems
have been developed to perform automated lifespan
and healtshpan experiments with minimum manual
input, and can be combined with existing scalable
automation technology such worm sorters, robotic
plate handlers, and chemical library screening tools,
allowing the study of many bacterial species and
pathways and host genotypes. Automated approaches
also include behavioural tracking which enable high-
throughput measurements of healthspan. For example,
The WormMotel allows the measurement not only of
lifespan, but also of behavioural decline in individual
animals. Another study used the Multi-Worm Tracker
computer-vision system (Swierczek et al. 2011) to
measure stimulated locomotion and study end-of-life
decrepitude (Podshivalova et al. 2017). C. elegans
ageing studies have traditionally been focused on
measuring lifespan, and the addition of healthspan
measurements adds an important dimension to our
understanding of ageing.
The biggest remaining question is what physiolog-
ical effects the gut microbiota generates in the host.
Most studies have focused on lifespan effects without
looking at how tissues and cells are affected. Using a
different approach, (Han et al. 2017) identified effects
resulting from bacterial CA production involving
mitochondrial fragmentation and mtUPR in the
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intestine, the tissue in direct contact with the micro-
biota, and beneficial effects in other tissues, including
a germline tumor progression model. Also (Zhao et al.
2017; Podshivalova et al. 2017) looked at the effect of
bacteria in tissues and showed that bacterial invasion
of the pharynx and the intestine occurs during ageing
and correlates with death. The continued and
expanded use of physiologically relevant approaches
will shine light on the mechanisms through which
bacterial pathways act to improve late life health.
Conclusions
It is becoming clear that the microbiome is linked to
human health. Current studies show that microbial
populations appear in specific disease states and
during senescence, and the challenge now is to
establish if there is a causal link between microbial
variation, disease and ageing. This requires robust
experimental models that allow the systematic manip-
ulation of variables to test the multitude of hypotheses
arisen during recent years. We are only just starting to
identify how bacterial pathways affect host biology
and ageing, and the factors shaping the composition of
the gut microbiota. Combining the nematode C.
elegans with bacterial model organisms allows
approaches that cannot easily be used in mammalian
systems, such as large-scale unbiased screens, auto-
mated approaches and in vivo imaging in combination
with genomics/genetics and metabolomics, allowing
the dissection of complex interactions and mecha-
nisms between the host and its microbiota. The
potential for this area of research is immense and
during the years to come will see further understand-
ing of complex host-microbiota interactions.
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